deltatrials
Recruiting PHASE1 INTERVENTIONAL 2-arm NCT03692429

alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells (alloSHRINK)

An Open-label, Phase I Study to Assess the Safety of Multiple Doses of CYAD-101, Administered After Standard FOLFOX or FOLFIRI Chemotherapy in Patients With Unresectable Metastatic Colorectal Cancer

Sponsor: Celyad Oncology SA

Conditions Unresectable Metastatic Colorectal Cancer
Interventions CYAD-101 FOLFIRI FOLFOX
Updated 10 times since 2018 Last updated: Nov 19, 2020 Started: Nov 28, 2018 Primary completion: Nov 28, 2021 Completion: Feb 17, 2036
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03692429, this PHASE1 trial focuses on Unresectable Metastatic Colorectal Cancer and remains actively recruiting participants. Sponsored by Celyad Oncology SA, it has been updated 10 times since 2018, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Nov 2018 – ~Jan 2019 · 2 months · monthly snapshotNot Yet Recruiting~Jan 2019 – ~Jun 2019 · 5 months · monthly snapshotRecruiting~Jun 2019 – ~Aug 2019 · 2 months · monthly snapshotRecruiting~Aug 2019 – ~Dec 2019 · 4 months · monthly snapshotRecruiting~Dec 2019 – ~Jul 2020 · 7 months · monthly snapshotRecruiting~Jul 2020 – ~Dec 2020 · 5 months · monthly snapshotRecruiting~Dec 2020 – ~Jan 2021 · 31 days · monthly snapshotRecruiting~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotRecruiting~Sep 2024 – present · 22 months · monthly snapshotRecruiting

Change History

10 versions recorded

  1. Sep 2024 — Present [monthly]

    Recruiting PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Recruiting PHASE1

  3. Jan 2021 — Jul 2024 [monthly]

    Recruiting PHASE1

  4. Dec 2020 — Jan 2021 [monthly]

    Recruiting PHASE1

  5. Jul 2020 — Dec 2020 [monthly]

    Recruiting PHASE1

▶ Show 5 earlier versions

  1. Dec 2019 — Jul 2020 [monthly]

    Recruiting PHASE1

  2. Aug 2019 — Dec 2019 [monthly]

    Recruiting PHASE1

  3. Jun 2019 — Aug 2019 [monthly]

    Recruiting PHASE1

  4. Jan 2019 — Jun 2019 [monthly]

    Recruiting PHASE1

    Status: Not Yet Recruiting → Recruiting

  5. Nov 2018 — Jan 2019 [monthly]

    Not Yet Recruiting PHASE1

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Celyad Oncology SA
Data source: Celyad Oncology SA

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations